No experience
Employment Type:
Job Category:
(This job is no longer available)
Mercury Systems | Hudson, NH
Grad Date

Not sure what types of jobs you are interested in?

Explore Jobs
Based on Your Education

Follow This Company

Job Description


In this role you have the opportunity to

Assists with preparation of analyses, reports, presentations, and research as defined by the department, to provide the company an opportunity to evaluate future hires. Confer with other supervisors to coordinate operations and activities within or between departments. Inspect materials, products, or equipment to detect defects or malfunctions. Other duties as assigned.

To be successful in this role you should have the following skills and abilities:

Knowledge of Microsoft Office tools (Excel & Word)

* Physical Demands/Working Conditions: The physical demands described here are representative of those that must be met by an employee to successfully perform the essential functions of this job. Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions.

About Mercury Systems

Mercury Computer Systems, Inc. (Mercury) designs, manufactures and markets high-performance computer, signal and image processing systems and software for embedded and other specialized computing markets. The Company’s primary market segments are aerospace and defense, which includes systems for radar, electronic warfare, sonar, command, control, communications, computers and intelligence and electro-optical; life sciences, which includes systems for medical diagnostic imaging and advanced visualization; semiconductor, which includes systems for semiconductor wafer inspection, reticle inspection and mask writing; geosciences, which includes software for oil and gas exploration, and telecommunications systems. Effective July 1, 2007, the Company had four segments: Advanced Computing Solutions, Visage Imaging, Visualization Software Group and Emerging Businesses Unit. In September 2008, Mercury sold the assets of SolMap Pharmaceuticals, its biotech venture, to FORMA Therapeutics.